Circulating monocyte chemoattractant protein-1 links to diabetic retinopathy in type 2 diabetic patients without renal dysfunction

被引：2

作者：

Morita S. ^{[1
]}

Ueyama M. ^{[1
]}

Shimajiri Y. ^{[1
]}

Yamana A. ^{[1
]}

Furuta M. ^{[1
]}

Sanke T. ^{[1
]}

机构：

[1] Department of Clinical Laboratory Medicine, Wakayama Medical University, Wakayama 641-8509

来源：

Diabetology International | 2010年 / 1卷 / 2期

关键词：

Adiponectin; Diabetic retinopathy; Insulin resistance; Monocyte chemoattractant protein-1;

D O I：

10.1007/s13340-010-0013-8

中图分类号：

学科分类号：

摘要：

Monocyte chemoattractant protein-1 (MCP-1) is a cytokine thought to be an important factor in adipose tissue inflammation in obese patients, but little is known about circulating MCP-1 in type 2 diabetic patients. We studied circulating MCP-1 levels in type 2 diabetic patients and their correlation with insulin resistance and other clinical data including chronic complications. In a preliminary study of 114 non-diabetic subjects, we found a significant correlation between serum MCP-1 level and estimated glomerular filtration rate (eGFR). We thus enrolled 185 type 2 diabetic patients and 91 non-diabetic subjects with an eGFR more than 60 ml/min/1. 73 m 2. There was no difference in serum MCP-1 levels between diabetic patients and non-diabetic subjects. Serum MCP-1 levels had no significant correlation with high-molecular-weight adiponectin in type 2 diabetic patients. In a limited number of type 2 diabetic patients (N = 112), serum MCP-1 levels had no significant correlation with homeostasis model assessment for insulin resistance (P = 0.075). Serum MCP-1 level was higher in proliferative retinopathy patients than in non-retinopathy patients (P = 0.028). Multiple regression analysis revealed that serum MCP-1 level was correlated with diabetic retinopathy (P = 0.007). We conclude that circulating MCP-1 level has little correlation with insulin resistance but is linked with diabetic retinopathy in type 2 diabetic patients. © 2011 The Japan Diabetes Society.

引用

页码：78 / 82

页数：4

共 27 条

[1]

Sell H., Eckel J., Monocyte chemotactic protein-1 and its role in insulin resistance, Curr Opin Lipidol, 18, pp. 258-262, (2007)

[2]

Kahn S.E., Hull R.L., Utzschneider K.M., Mechanisms linking obesity to insulin resistance and type 2 diabetes, Nature, 444, pp. 840-846, (2006)

[3]

Deepa R., Velmurugan K., Arvind K., Sivaram P., Sientay C., Uday S., Mohan V., Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance--the Chennai Urban Rural Epidemiology Study (CURES), Metabolism, 55, pp. 1232-1238, (2006)

[4]

Di Benedetto A., Russo G.T., Corrado F., Di Cesare E., Alessi E., Nicocia G., D'Anna R., Cucinotta D., Inflammatory markers in women with a recent history of gestational diabetes mellitus, J Endocrinol Invest, 28, pp. 34-38, (2005)

[5]

Chiarelli F., Cipollone F., Mohn A., Marini M., Iezzi A., Fazia M., Tumini S., de Cesare D., Pomilio M., Pierdomenico S.D., Di Gioacchino M., Cuccurullo F., Mezzetti A., Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes, Diabetes Care, 25, pp. 1829-1834, (2002)

[6]

Tesch G.H., MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy, Am J Physiol Renal Physiol, 294, (2008)

[7]

Harada C., Okumura A., Namekata K., Nakamura K., Mitamura Y., Ohguro H., Harada T., Role of monocyte chemotactic protein-1 and nuclear factor kappa B in the pathogenesis of proliferative diabetic retinopathy, Diabetes Res Clin Pract, 74, pp. 249-256, (2006)

[8]

Hernandez C., Segura R.M., Fonollosa A., Carrasco E., Francisco G., Simo R., Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy, Diabetes Med, 22, pp. 719-722, (2005)

[9]

Takeda T., Gejyo F., New concept of chronic kidney disease and blockade of renin-angiotensin system, Nippon Rinsho, 65, pp. 1727-1733, (2007)

[10]

Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, pp. 412-419, (1985)

← 1 2 3 →